Resistance Characterization of Hepatitis C Virus Genotype 2 from Japanese Patients Treated with Ombitasvir and Paritaprevir/Ritonavir.
about
Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience.Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials
P2860
Resistance Characterization of Hepatitis C Virus Genotype 2 from Japanese Patients Treated with Ombitasvir and Paritaprevir/Ritonavir.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Resistance Characterization of ...... ir and Paritaprevir/Ritonavir.
@en
type
label
Resistance Characterization of ...... ir and Paritaprevir/Ritonavir.
@en
prefLabel
Resistance Characterization of ...... ir and Paritaprevir/Ritonavir.
@en
P2093
P2860
P356
P1476
Resistance characterization of ...... vir and paritaprevir/ritonavir
@en
P2093
Carolyn Setze
Christine Collins
Hiromitsu Kumada
Jill Beyer
Katia Alves
Lino Rodrigues
Margaret Burroughs
Michelle Irvin
Preethi Krishnan
Rakesh Tripathi
P2860
P304
P356
10.1002/JMV.24923
P577
2017-09-22T00:00:00Z